← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #785 OF 1,000 MOST-CITED

Equipment calibration frequency

FDA cited this observation 20 times across 20 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Biologics20
BY FISCAL YEAR
FY20262
FY20242
FY20223
FY20212
FY20194
FY20181
FY20176

How FDA worded it — real examples

Equipment used in the storage and distribution of blood and blood components is not observed, standardized and calibrated with at least the frequency required.

Octapharma Plasma Inc · Mesa, Arizona · Biologics · 2026-05-14

Equipment used in the collection of blood and blood components is not observed, standardized and calibrated with at least the frequency required.

LifeSouth Community Blood Centers Inc · Columbus, Georgia · Biologics · 2026-02-11

Equipment used in the collection, processing and storage and distribution of blood and blood components is not observed, standardized and calibrated with at least the frequency required.

Carter BloodCare - Texoma · Sherman, Texas · Biologics · 2024-08-23

Equipment used in the collection and processing of blood and blood components is not observed, standardized and calibrated with at least the frequency required.

LifeSouth Community Blood Centers, Inc · Gainesville, Georgia · Biologics · 2024-02-07

Equipment used in the processing of blood and blood components is not observed, standardized and calibrated with at least the frequency required.

Innovative Transfusion Medicine, Inc. · Miami Lakes, Florida · Biologics · 2022-06-24

Equipment used in the collection and processing of blood and blood components is not observed, standardized and calibrated with at least the frequency required.

Blood Assurance, Inc. · Columbia, Tennessee · Biologics · 2022-02-14

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Biologics industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →